TCTMD: Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? MedPage Today: Patients Can Manage Their Own Warfarin Just Fine, Study Suggests Patient self-management of warfarin is endorsed by U.S.
guidelines, but an in-clinic approach remains the norm due to clinician reluctance and other barriers. Among patients who agreed to make their ... Healio: Patients using warfarin may have higher risk of death after trauma Medscape: Warfarin Use in Patients With End-Stage Renal Disease May Increase Stroke Risk — Use of warfarin as chemoprophylaxis in patients with atrial fibrillation and end-stage renal disease (ESRD) may paradoxically increase stroke risk, according to the results of a ... Warfarin Use in Patients With End-Stage Renal Disease May Increase Stroke Risk Monthly Prescribing Reference: What Patients Don’t Know About Warfarin Could Hurt Them Patients may not be fully aware of the foods and drugs that can interfere with warfarin treatment and cause serious side effects According to new research presented at EuroHeartCare 2016, patients may ...
patient teaching warfarin, The New England Journal of Medicine: A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome Many patients with the antiphospholipid antibody syndrome and recurrent thrombosis receive doses of warfarin adjusted to achieve an international normalized ratio (INR) of more than 3.0. However, ... A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ... HealthDay News — Obese patients prescribed warfarin have a higher risk of experiencing a bleeding event compared with their normal-weight counterparts, study findings suggest. To evaluate the effect ...
patient teaching warfarin, ascopubs.org: DOACs vs warfarin: Rethinking anticoagulation strategies for portal vein thrombosis prophylaxis in patients with increased risk. Inpatient burden of chimeric antigen receptor T-cell therapy: A National Inpatient Sample study. Time Point Incidence Rate per 100 PY (Warfarin, 95% CI) Incidence Rate per 100 PY (DOAC, 95% CI) Hazard ... DOACs vs warfarin: Rethinking anticoagulation strategies for portal vein thrombosis prophylaxis in patients with increased risk. The New England Journal of Medicine: Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm It is unknown whether warfarin or aspirin therapy is superior for patients with heart failure who are in sinus rhythm. We designed this trial to determine whether warfarin (with a target international ...
